This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          June 17, 2014

Home  |   About ASHI  |   Education  |   Publications  |   Meetings  |   Careers  |   News  |   Lab Center


 
ASHI EDUCATIONAL REGIONAL WORKSHOP - BALTIMORE
June 19–21

REGISTRATION

Online advance registration has closed but you can still attend this valuable workshop! Contact Julie DiCarlo at jdicarlo@ahint.com to register. Topics and speakers include the following:
  • UNOS Update: Meeting the Challenge of Change
  • Opening Pandora’s Box: Antibody Targets Beyond HLA
  • Presented by Julie Houp, CHS

  • Chronicles from The HLA Laboratory: High Resolution Typing Methods
  • Navigating the Road to NGS Implementation in the Clinical Laboratory
  • Presented by Medhat Askar, M.D., Ph.D., D(ABHI)

  • Detection of Complement Binding Antibodies; C1q Assay and Beyond
  • Optimization of Flow Cytometric Crossmatch, It’s About Time
  • Presented by Robert Liwski, M.D.

  • The Reality of the Virtual Crossmatch
  • Transplanting the Highly Sensitized Patient – Biology vs Pharmacology
  • Presented by Robert Bray, Ph.D., D(ABHI)
Also featured will be innovative technology vendor presentations and case study presentations.

For complete details about the workshop go here.
INTERNATIONAL SUMMER SCHOOL – BOULDER, COLORADO
Oct. 15-18

APPLICATION DEADLINE EXTENDED

The application deadline (for ASHI, EFI or APHIA members only) has been extended to July 2. Please use this time to prepare your application to join us! Not only will you have access to expert programming but you'll also be a short ride away from ASHI's 40th Annual Meeting taking place in Denver, Colorado, Oct. 20-24.

To allow for intense, interactive discussions, a total of only 50 students will be accepted from all 3 sponsoring societies.

This year's International Summer School for Histocompatibility and Immunogenetics is organized by ASHI with support from EFI (European Federation for Immunogenetics) and APHIA (Asia-Pacific Histocompatibility and Immunogenetics Association).

The low tuition fee of $250 includes the following:
  • Registration
  • Three nights hotel accommodations at the Renaissance Boulder Flatiron
  • All meals for the duration of the Summer School
For program details and how to apply, visit www.ashi-hla.org/events/int-ummer-school.
ASHI ANNUAL MEETING – DENVER, COLORADO Oct. 20–24

Join us in Denver, Colorado, for ASHI’s 40th Annual Meeting! The official annual meeting website will be available very soon offering program details, registration information, news updates and more — stay tuned!


INDUSTRY NEWS


Findings add surprising new dimension to understanding of antibody repertoires
News-Medical
As elite soldiers of the body's immune response, B-cells serve as a vast standing army ready to recognize and destroy invading antigens, including infections and cancer cells. To do so, each new B-cell comes equipped with its own highly specialized weapon, a unique antibody protein that selectively binds to specific parts of the antigen. The key to this specialization is the antigen-binding region that tailors each B-cell to a particular antigen, determining whether B-cells survive boot camp and are selected for maturation and survival, or wash out and die.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Adopting immunity
Australian Life Scientist
Doctors Leighton Clancy and Emily Blyth are developing and conducting clinical trials on virus-specific and tumor-specific T-cells with the ultimate goal of producing an improved treatment package for bone marrow transplant patients. Though a transplant may cure a patient of their disease, their resultant poor immune function can lead to them dying from infection. In fact, one of the major morbidities within the first 12 months after a bone marrow transplant is infection.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Preimplantation genetic screening improved with next generation sequencing
Medical Research News
This study describes findings from first and second of a three-phase strategy to validate the use of next-generation sequencing (NGS) for comprehensive aneuploidy screening, as a preclinical step toward its routine use in the diagnosis of chromosomal aneuploidy on embryos. The first phase involved a large preclinical validation study on single cells, and demonstrated that the NGS-based 24-aneuploidy screening protocol was accurate and reliable. The results provided 100 percent consistency for aneuploid embryo call with array-CGH, the highly validated method of aneuploidy screening.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASHI Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lauren Swan, Content Editor, 202.684.7496  
Contribute news


Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of ASHI Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063